SPY456.49-8.23 -1.77%
DIA353.85-5.29 -1.47%
IXIC14,506.90-386.86 -2.60%

BRIEF-Hin Sang Group (International) Says Unit Entered Into Cooperation Agreement With Hongli Homologous Biotechnology

reuters.com · 12/29/2021 09:14
BRIEF-Hin Sang Group (International) Says Unit Entered Into Cooperation Agreement With Hongli Homologous Biotechnology

- Hin Sang Group (International) Holding Co Ltd 6893.HK:

  • UNIT ENTERED INTO A COOPERATION AGREEMENT WITH HONGLI HOMOLOGOUS BIOTECHNOLOGY

  • AGREEMENT TO ESTABLISH PENGZU HIN SANG PAVILION (GUANGDONG) BRAND MANAGEMENT CO

  • REGISTERED SHARE CAPITAL OF NEW CO RMB10 MILLION

Source text for Eikon: ID:nHKS36K4sy

Further company coverage: 6893.HK


((Reuters.Briefs@thomsonreuters.com;))